ReviewJournal of clinical medicine2026

GLP-1-Based Therapies for Cardiovascular Risk Reduction in Kazakhstan: Evidence, Affordability, Equity and Implementation Considerations.

Kulzhan Berikkhanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.